Czech Republic - Hospital Average Length of Stay for Malignant Neoplasm of Bladder
Since 2014, Czech Republic Hospital Average Length of Stay for Malignant Neoplasm of Bladder decreased by 1.2% year on year. With 6.3 Days in 2019, the country was number 10 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Bladder. Czech Republic is overtaken by Latvia, which was number 9 at 6.6 Days and is followed by Slovenia with 6.2 Days. South Korea lead the ranking with 11.3 Days in 2019, stable compared to 2018. Iceland recorded the best 5 years average growth at +6.9% per year, while Mexico witnessed the worst performance at -5% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 6.30 |
| 2018 | 6.30 |
| 2017 | 6.50 |
| 2016 | 6.60 |
| 2015 | 6.60 |
Download all data from 2000 to 2019
How does Czech Republic rank in Hospital Average Length of Stay for Malignant Neoplasm of Bladder?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
11.30 | 2019 | +0.0 % | +0.7 % | View data | |
| 2 |
#2
Iceland
|
8.50 | 2019 | +2.4 % | +6.9 % | View data | |
| 9 |
#9
Latvia
|
6.60 | 2019 | +1.5 % | -0.9 % | View data | |
| 10 |
#10
Czech Republic
|
6.30 | 2019 | +0.0 % | -1.2 % | View data | |
| 11 |
#11
Slovenia
|
6.20 | 2019 | -1.6 % | -1.5 % | View data | |